Medical Devices & Pharma Articles
This week's top stories include Eli Lilly's European first pill, BMS' Texan manufacturing, Novo Nordisk's GLP-1, AWS AI partnership & P&G's wellness move
Beiersdorf's TopiC.A, a patented cosmetic ingredient based on two skin-native probiotic strains, could transform approaches to acne treatment
Novo Nordisk appoints Omnicom to lead US media for GLP-1 medicines targeting diabetes and obesity, as healthcare marketing for Wegovy and Ozempic expands
The UK has become the first European country to approve Eli Lilly’s oral GLP-1 medicine orforglipron for weight management and type 2 diabetes
State-of-the-art facility in Houston, Texas, will create nearly 500 specialist jobs and accelerate Bristol Myers Squibb’s delivery of next-gen medicines
Amid a growing outbreak, Oxford University researchers and Moderna announced that clinical trials for a Bundibugyo virus strain vaccine have begun
P&G's acquisition of practitioner-trusted supplements brand Thorne marks its biggest move yet into science-backed, personalised wellness
Johnson & Johnson's Innovative Medicine business is set for a leadership change as EVP Jennifer Taubert retires and Tom Cavanaugh takes the helm